Showing results (131-140 of 976) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|May 19, 2021
Circulating amino acids and amino acid-related metabolites and risk of breast cancer among predominantly premenopausal womenOana A Zeleznik, Raji Balasubramanian, Yibai Zhao, et al.
NPJ Breast Cancer|September 7, 2021
Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acidNeelima Vidula, Sally Greenberg, Laura Petrillo, et al.
NPJ Breast Cancer|August 20, 2021
Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin AmericaJosef S Herzog, Yanin Chavarri-Guerra, Danielle Castillo, et al.
NPJ Breast Cancer|September 10, 2021
Clinical consequences of BRCA2 hypomorphismLaia Castells-Roca, Sara Gutiérrez-Enríquez, Sandra Bonache, et al.
NPJ Breast Cancer|January 26, 2023
Concomitant analyses of intratumoral microbiota and genomic features reveal distinct racial differences in breast cancerSheetal Parida, Sumit Siddharth, Yuqing Xia, et al.
NPJ Breast Cancer|November 25, 2025
Racial and demographic disparities in glp-1ra use among breast cancer patients with Type 2 DiabetesJasmin Hundal, Omer S Ashruf, Hong Li, et al.
NPJ Breast Cancer|November 13, 2025
Evolving incidence patterns for locally advanced operable breast cancer by receptor status: SEER 2010-2021Alexandra Thomas, Anthony Rhoads, Erica L Mayer, et al.
NPJ Breast Cancer|December 24, 2025
Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implicationsGaia Griguolo, Michele Bottosso, Laia Paré, et al.
NPJ Breast Cancer|October 28, 2025
Breast density in MRI: an AI-based quantification and relationship to assessment in mammographyYaqian Chen, Lin Li, Hanxue Gu, et al.
NPJ Breast Cancer|October 24, 2025
CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trialAndrea E Wahner Hendrickson, Karen S Flatten, Taylor M Weiskittel, et al.
Pageof 98